Skip to main content

Measles Vaccine Developer Samuel Katz Dies at 95

He also worked on immunizations against polio, rubella, influenza, and more.

Written byLisa Winter
| 3 min read
Sam Katz looks at camera
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Measles was once a common childhood ailment, claiming millions of lives globally each year. Samuel Katz, one of the primary developers of the attenuated measles vaccine that helped to slash that death toll, died at his home in Chapel Hill, North Carolina, on October 31 at age 95.

Katz was born in New Hampshire on May 29, 1927. According to an obituary from Duke University, he completed a year at Dartmouth College before enlisting in the United States Navy in 1945. Since World War II was nearing its end, he was sent to work in a San Diego hospital. His interest in medicine was piqued, and when he returned to Dartmouth, he completed his undergraduate degree and then a two-year preclinical program in 1950. He attended medical school at Harvard University, graduating in 1952. Katz then stayed in Boston, doing training and fellowships at hospitals around the city.

According to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays